Key result
ACTEN (Fortigel and Fucoidan) reduced knee osteoarthritis pain by 49.4% at 12 weeks, with no significant difference compared to the active control COMBIART.
Why the study?
Osteoarthritis is a common progressive joint condition causing significant discomfort and disability with increasing prevalence with age and known risk factors.
RCT (n=126)
Randomly assigned
Yes
Answers are grounded in this paper and cite their sources.
May support ACTEN as a comparable option for knee OA pain; extends RCT evidence for Fortigel-Fucoidan combinations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Martin-Martin Ls (2016) conducted an RCT in Gonarthrosis (Knee Osteoarthritis) (n=126). ACTEN (Fortigel and Fucoidan) vs. COMBIART (Glucosamine 500mg, Chondroitin Sulfate 400mg, Hyaluronic Acid 50mg, Vitamin C 100mg) was evaluated on Reduction in Visual Analog Scale (VAS) score at 3 months (%) (p=Not significant). ACTEN (Fortigel and Fucoidan) reduced knee osteoarthritis pain by 49.4% at 12 weeks, with no significant difference compared to the active control COMBIART.
Synapse has enriched 10 related papers. Consider them for comparative context: